{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:08:21Z","timestamp":1789024101104,"version":"build-2803163510"},"reference-count":351,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0 http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease that targets motor neurons in the cerebral cortex, medulla oblongata, and spinal cord. This review focuses on the current concepts in the aetiopathogenesis and diagnosis of amyotrophic lateral sclerosis, aiming to explore potential neural repair strategies (curative and\/or progression-retarding therapeutics). Recent studies have highlighted that the complex pathogenesis of amyotrophic lateral sclerosis is related to its multifactorial aetiology, including proteostasis disruption, impaired RNA metabolism and DNA repair, cytoskeletal and axonal transport defects, excitotoxicity, neuroinflammation, mitochondrial dysfunction, oligodendrocyte dysfunction, nucleocytoplasmic transport deficits, lipid dyshomeostasis, and autophagy. Several approved drugs are currently used to treat patients with amyotrophic lateral sclerosis; however, their curative efficacy is limited. Thus, the search for effective therapeutic strategies for amyotrophic lateral sclerosis requires a comprehensive understanding of its pathogenesis. Current evidence indicates that a single drug cannot provide a satisfactory therapeutic effect. Additionally, multiple pathophysiological processes and related targets are involved in the pathogenesis of amyotrophic lateral sclerosis. Therefore, research on multi-target synchronous interventions may be the path forward for discovering and developing potential neural repair strategies.<\/jats:p>\n                  <jats:p\/>","DOI":"10.4103\/nrr.nrr-d-25-00221","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:00:08Z","timestamp":1770008408000},"page":"5181-5195","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions"],"prefix":"10.4103","volume":"21","author":[{"given":"Jingjing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology, Yingtan People\u2019s Hospital, Yingtan, Jiangxi Province, China"},{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital; The Clinical College of Nanchang Medical College; The First Affiliated Hospital of Nanchang Medical College; Xiangya Hospital of Central South University, Jiangxi Hospital; National Regional Center for Neurological Disease, Nanchang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yingtan People\u2019s Hospital, Yingtan, Jiangxi Province, China"},{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital; The Clinical College of Nanchang Medical College; The First Affiliated Hospital of Nanchang Medical College; Xiangya Hospital of Central South University, Jiangxi Hospital; National Regional Center for Neurological Disease, Nanchang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Nanchang, Nanchang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-3434","authenticated-orcid":false,"given":"Renshi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yingtan People\u2019s Hospital, Yingtan, Jiangxi Province, China"},{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital; The Clinical College of Nanchang Medical College; The First Affiliated Hospital of Nanchang Medical College; Xiangya Hospital of Central South University, Jiangxi Hospital; National Regional Center for Neurological Disease, Nanchang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"R1-20260910","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1042\/BST20130142","article-title":"The intriguing case of motor neuron disease: ALS and SMA come closer","volume":"41","author":"Achsel","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"R2-20260910","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: translating genetic discoveries into therapies","volume":"24","author":"Ak\u00e7imen","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R3-20260910","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of ALS: a conspiracy of genes, environment and time","volume":"9","author":"Al-Chalabi","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R4-20260910","doi-asserted-by":"crossref","first-page":"e0274615","DOI":"10.1371\/journal.pone.0274615","article-title":"Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease","volume":"17","author":"Alexander","year":"2022","journal-title":"PLoS One"},{"key":"R5-20260910","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00018-016-2372-1","article-title":"Profilin1 biology and its mutation, actin(g) in disease","volume":"74","author":"Alkam","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"R6-20260910","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/ph17101391","article-title":"Amyotrophic lateral sclerosis: insights and new prospects in disease pathophysiology, biomarkers and therapies","volume":"17","author":"Al-Khayri","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"R7-20260910","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","article-title":"Parkinson\u2019s disease risk and hyperhomocysteinemia: the possible link","volume":"43","author":"Al-Kuraishy","year":"2023","journal-title":"Cell Mol Neurobio"},{"key":"R8-20260910","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","article-title":"The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"R9-20260910","doi-asserted-by":"crossref","first-page":"102084","DOI":"10.1016\/j.arr.2023.102084","article-title":"The link between metabolic syndrome and Alzheimer disease: a mutual relationship and long rigorous investigation","volume":"91","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R10-20260910","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","article-title":"The beneficial role of autophagy in multiple sclerosis: yes or no?","volume":"20","author":"Al-Kuraishy","year":"2024","journal-title":"Autophagy"},{"key":"R11-20260910","doi-asserted-by":"crossref","first-page":"1422912","DOI":"10.3389\/fnins.2024.1422912","article-title":"The role of statins in amyotrophic lateral sclerosis: protective or not?","volume":"18","author":"Al-Kuraishy","year":"2024","journal-title":"Front Neurosci"},{"key":"R12-20260910","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2009.180232","article-title":"Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"81","author":"Alonso","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20260910","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.3390\/ijms252010900","article-title":"A review of biomarkers of amyotrophic lateral sclerosis: a pathophysiologic approach","volume":"25","author":"Alshehri","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R14-20260910","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: a review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol Ther"},{"key":"R15-20260910","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases--an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"R16-20260910","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymeth.2010.11.006","article-title":"TDP-43 toxicity in yeast","volume":"53","author":"Armakola","year":"2011","journal-title":"Methods"},{"key":"R17-20260910","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2007.06.021","article-title":"Sports and trauma in amyotrophic lateral sclerosis revisited","volume":"262","author":"Armon","year":"2007","journal-title":"J Neurol Sci"},{"key":"R18-20260910","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.3390\/ijms25115587","article-title":"Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration","volume":"25","author":"Arnold","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R19-20260910","first-page":"22","article-title":"New drug approved for ALS","volume":"123","author":"Aschenbrenner","year":"2023","journal-title":"Am J Nurs"},{"key":"R20-20260910","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41467-021-22145-9","article-title":"TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in vitro","volume":"12","author":"Baek","year":"2021","journal-title":"Nat Commun"},{"key":"R21-20260910","doi-asserted-by":"crossref","first-page":"177187","DOI":"10.1016\/j.ejphar.2024.177187","article-title":"Therapeutic targeting of the oxidative stress generated by pathological molecular pathways in the neurodegenerative diseases, ALS and Huntington\u2019s","volume":"987","author":"Bajpai","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"R22-20260910","first-page":"2378","article-title":"Axonal transport defects are a common phenotype in Drosophila models of ALS","volume":"25","author":"Baldwin","year":"2016","journal-title":"Hum Mol Genet"},{"key":"R23-20260910","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1474-4422(25)00109-7","article-title":"Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy","volume":"24","author":"Balendra","year":"2025","journal-title":"Lancet Neurol"},{"key":"R24-20260910","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-020-02203-0","article-title":"The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis","volume":"140","author":"Bampton","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R25-20260910","doi-asserted-by":"crossref","first-page":"2474796","DOI":"10.1080\/27694127.2025.2474796","article-title":"The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)","volume":"4","author":"Beckers","year":"2025","journal-title":"Autophagy Rep."},{"key":"R26-20260910","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ene.15573","article-title":"Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial","volume":"30","author":"Beghi","year":"2023","journal-title":"Eur J Neurol"},{"key":"R27-20260910","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s13311-022-01237-4","article-title":"Design of a randomized, placebo-controlled, phase 3 trial of tofersen initiated in clinically presymptomatic SOD1 variant carriers: the ATLAS study","volume":"19","author":"Benatar","year":"2022","journal-title":"Neurotherapeutics"},{"key":"R28-20260910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-019-0327-3","article-title":"Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities","volume":"14","author":"Bercier","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R29-20260910","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41419-017-0125-1","article-title":"Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?","volume":"9","author":"Bernard-Marissal","year":"2018","journal-title":"Cell Death Dis"},{"key":"R30-20260910","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1073\/pnas.1006869107","article-title":"Deficits in axonal transport precede ALS symptoms in vivo","volume":"107","author":"Bilsland","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-20260910","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"R32-20260910","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.3390\/jcm12155055","article-title":"Amyotrophic lateral sclerosis: advances and prospects","volume":"12","author":"Boentert","year":"2023","journal-title":"J Clin Med"},{"key":"R33-20260910","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/ijms21072395","article-title":"Abnormal upregulation of GPR17 receptor contributes to oligodendrocyte dysfunction in SOD1 G93A mice","volume":"21","author":"Bonfanti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R34-20260910","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1039\/c2mt20052j","article-title":"Metal imaging in neurodegenerative diseases","volume":"4","author":"Bourassa","year":"2012","journal-title":"Metallomics"},{"key":"R35-20260910","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neulet.2016.04.065","article-title":"Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives","volume":"636","author":"Bozzo","year":"2017","journal-title":"Neurosci Lett"},{"key":"R36-20260910","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ncl.2020.03.013","article-title":"ALS: Management problems","volume":"38","author":"Brent","year":"2020","journal-title":"Neurol Clin"},{"key":"R37-20260910","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R38-20260910","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"key":"R39-20260910","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1128\/MCB.01730-13","article-title":"From hypothesis to mechanism: uncovering nuclear pore complex links to gene expression","volume":"34","author":"Burns","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R40-20260910","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/hmg\/ddx397","article-title":"In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions","volume":"27","author":"Burstein","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R41-20260910","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fgene.2018.00712","article-title":"RNA dysregulation in amyotrophic lateral sclerosis","volume":"9","author":"Butti","year":"2018","journal-title":"Front Genet"},{"key":"R42-20260910","doi-asserted-by":"crossref","first-page":"102062","DOI":"10.1016\/j.jbc.2022.102062","article-title":"Protein interaction networks in neurodegenerative diseases: from physiological function to aggregation","volume":"298","author":"Calabrese","year":"2022","journal-title":"J Biol Chem"},{"key":"R43-20260910","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1038\/s41467-024-49196-y","article-title":"Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target","volume":"15","author":"Caldi Gomes","year":"2024","journal-title":"Nat Commun"},{"key":"R44-20260910","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/WCO.0000000000001279","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications","volume":"37","author":"Calma","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"R45-20260910","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ana.27201","article-title":"Brain metabolic features of FUS-ALS: a 2-[(18)F]FDG-PET study","volume":"97","author":"Canosa","year":"2025","journal-title":"Ann Neurol"},{"key":"R46-20260910","doi-asserted-by":"crossref","first-page":"e16588","DOI":"10.1111\/ene.16588","article-title":"Sex-related differences in amyotrophic lateral sclerosis: a 2-[(18)F]FDG-PET study","volume":"32","author":"Canosa","year":"2025","journal-title":"Eur J Neurol"},{"key":"R47-20260910","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.3390\/ijms20184388","article-title":"Gene therapy for ALS-A perspective","volume":"20","author":"Cappella","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R48-20260910","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/21678421.2021.1946089","article-title":"Percutaneous gastrostomy in amyotrophic lateral sclerosis: a review","volume":"23","author":"Castanheira","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R49-20260910","doi-asserted-by":"crossref","first-page":"594975","DOI":"10.3389\/fncel.2020.594975","article-title":"The neglected genes of ALS: cytoskeletal dynamics impact synaptic degeneration in ALS","volume":"14","author":"Castellanos-Montiel","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R50-20260910","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/biom14111362","article-title":"Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and Alzheimer\u2019s disease","volume":"14","author":"Cerasuolo","year":"2024","journal-title":"Biomolecules"},{"key":"R51-20260910","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","article-title":"Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis","volume":"9","author":"Chaves-Filho","year":"2019","journal-title":"Sci Rep"},{"key":"R52-20260910","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/cells10071789","article-title":"Amyotrophic lateral sclerosis (ALS): stressed by Dysfunctional mitochondria-endoplasmic reticulum contacts (MERCs)","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"key":"R53-20260910","doi-asserted-by":"crossref","first-page":"104776","DOI":"10.1016\/j.jprot.2022.104776","article-title":"Proteomics analysis indicates the involvement of immunity and inflammation in the onset stage of SOD1-G93A mouse model of ALS","volume":"272","author":"Chen","year":"2023","journal-title":"J Proteomics"},{"key":"R54-20260910","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1567202617666200409125227","article-title":"Riluzole exhibits no therapeutic efficacy on a transgenic rat model of amyotrophic lateral sclerosis","volume":"17","author":"Chen","year":"2020","journal-title":"Curr Neurovasc Res"},{"key":"R55-20260910","doi-asserted-by":"crossref","first-page":"111229","DOI":"10.1016\/j.brainresbull.2025.111229","article-title":"Differed brain spontaneous neural activity between limb-onset and bulbar-onset amyotrophic lateral sclerosis patients","volume":"221","author":"Chen","year":"2025","journal-title":"Brain Res Bull"},{"key":"R56-20260910","doi-asserted-by":"crossref","first-page":"147904","DOI":"10.1016\/j.brainres.2022.147904","article-title":"The pathogenesis of amyotrophic lateral sclerosis: mitochondrial dysfunction, protein misfolding and epigenetics","volume":"1786","author":"Chen","year":"2022","journal-title":"Brain Res"},{"key":"R57-20260910","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13238-011-1065-7","article-title":"Expression of human FUS protein in Drosophila leads to progressive neurodegeneration","volume":"2","author":"Chen","year":"2011","journal-title":"Protein Cell"},{"key":"R58-20260910","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/ph14010029","article-title":"Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis","volume":"14","author":"Cho","year":"2020","journal-title":"Pharmaceuticals"},{"key":"R59-20260910","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41419-020-03102-8","article-title":"Prevention of mitochondrial impairment by inhibition of protein phosphatase 1 activity in amyotrophic lateral sclerosis","volume":"11","author":"Choi","year":"2020","journal-title":"Cell Death Dis"},{"key":"R60-20260910","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15548627.2021.1926656","article-title":"Autophagy and ALS: mechanistic insights and therapeutic implications","volume":"18","author":"Chua","year":"2022","journal-title":"Autophagy"},{"key":"R61-20260910","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbi.2024.12.010","article-title":"GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosis","volume":"124","author":"Cocozza","year":"2025","journal-title":"Brain Behav Immun"},{"key":"R62-20260910","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41598-021-81599-5","article-title":"Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis","volume":"11","author":"Conti","year":"2021","journal-title":"Sci Rep"},{"key":"R63-20260910","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1100\/2011\/853474","article-title":"An overview of DNA repair in amyotrophic lateral sclerosis","volume":"11","author":"Copped\u00e8","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"R64-20260910","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review","volume":"69","author":"Costa","year":"2012","journal-title":"Arch Neurol"},{"key":"R65-20260910","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12640-017-9753-6","article-title":"BMAA and neurodegenerative illness","volume":"33","author":"Cox","year":"2018","journal-title":"Neurotox Res"},{"key":"R66-20260910","doi-asserted-by":"crossref","first-page":"eabe1923","DOI":"10.1126\/scitranslmed.abe1923","article-title":"Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS","volume":"13","author":"Coyne","year":"2021","journal-title":"Sci Transl Med"},{"key":"R67-20260910","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.neuron.2020.06.027","article-title":"G4C2 Repeat RNA Initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS\/FTD","volume":"107","author":"Coyne","year":"2020","journal-title":"Neuron"},{"key":"R68-20260910","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12031-022-02029-3","article-title":"Autophagy dysfunction in ALS: from transport to protein degradation","volume":"72","author":"Cozzi","year":"2022","journal-title":"J Mol Neurosci"},{"key":"R69-20260910","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1021\/acs.jmedchem.3c02422","article-title":"Discovery of DNL343: a potent, selective, and brain-penetrant eIF2B activator designed for the treatment of neurodegenerative diseases","volume":"67","author":"Craig","year":"2024","journal-title":"J Med Chem"},{"key":"R70-20260910","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-11-42","article-title":"Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model","volume":"11","author":"Cui","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R71-20260910","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/cells10020369","article-title":"Loss of COX4I1 leads to combined respiratory chain deficiency and impaired mitochondrial protein synthesis","volume":"10","author":"\u010cun\u00e1tov\u00e1","year":"2021","journal-title":"Cells"},{"key":"R72-20260910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5021694","article-title":"Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention","volume":"2020","author":"Cunha-Oliveira","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R73-20260910","first-page":"279","article-title":"Rac1 at the crossroad of actin dynamics and neuroinflammation in amyotrophic lateral sclerosis","volume":"8","author":"D\u2019Ambrosi","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"R74-20260910","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jnc.15126","article-title":"Wild-type and mutant SOD1 localizes to RNA-rich structures in cells and mice but does not bind RNA","volume":"156","author":"Da Ros","year":"2021","journal-title":"J Neurochem"},{"key":"R75-20260910","doi-asserted-by":"crossref","first-page":"653688","DOI":"10.3389\/fncel.2021.653688","article-title":"The role of mitochondrial dysfunction and er stress in TDP-43 and C9ORF72 ALS","volume":"15","author":"Dafinca","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"R76-20260910","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","article-title":"Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content","volume":"16","author":"De Vos","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R77-20260910","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/hmg\/ddr559","article-title":"VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis","volume":"21","author":"De Vos","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R78-20260910","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","article-title":"Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research?","volume":"105","author":"De Vos","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R79-20260910","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"R80-20260910","doi-asserted-by":"crossref","first-page":"E9678","DOI":"10.1073\/pnas.1806655115","article-title":"FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models","volume":"115","author":"Deng","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R81-20260910","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"key":"R82-20260910","doi-asserted-by":"crossref","first-page":"114902","DOI":"10.1016\/j.intimp.2025.114902","article-title":"cGAS-STING and neurodegenerative diseases: a molecular crosstalk and therapeutic perspective","volume":"159","author":"Dhapola","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"R83-20260910","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00109-024-02419-7","article-title":"Evidence for alterations in lipid profiles and biophysical properties of lipid rafts from spinal cord in sporadic amyotrophic lateral sclerosis","volume":"102","author":"D\u00edaz","year":"2024","journal-title":"J Mol Med (Berl)"},{"key":"R84-20260910","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/cdd.2017.88","article-title":"The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins","volume":"24","author":"Dreser","year":"2017","journal-title":"Cell Death Differ"},{"key":"R85-20260910","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1523\/JNEUROSCI.5411-09.2010","article-title":"Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death","volume":"30","author":"Duplan","year":"2010","journal-title":"J Neurosci"},{"key":"R86-20260910","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/1873-3468.12646","article-title":"TDP-43 and FUS en route from the nucleus to the cytoplasm","volume":"591","author":"Ederle","year":"2017","journal-title":"FEBS Lett"},{"key":"R87-20260910","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/brainsci15050498","article-title":"Amyotrophic lateral sclerosis: recent considerations for diagnosis, pathogenesis and therapy","volume":"15","author":"Eisen","year":"2025","journal-title":"Brain Sci"},{"key":"R88-20260910","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41582-024-01049-4","article-title":"Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis","volume":"21","author":"Faller","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"R89-20260910","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3390\/cells11132066","article-title":"Gene therapy in amyotrophic lateral sclerosis","volume":"11","author":"Fang","year":"2022","journal-title":"Cells"},{"key":"R90-20260910","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"R91-20260910","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","article-title":"Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression","volume":"14","author":"Femiano","year":"2024","journal-title":"Sci Rep"},{"key":"R92-20260910","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/15548627.2019.1633862","article-title":"MAPT\/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration","volume":"16","author":"Feng","year":"2020","journal-title":"Autophagy"},{"key":"R93-20260910","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12916-024-03781-6","article-title":"Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Feng","year":"2024","journal-title":"BMC Med"},{"key":"R94-20260910","doi-asserted-by":"crossref","first-page":"E6496","DOI":"10.1073\/pnas.1607496113","article-title":"Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism","volume":"113","author":"Ferraiuolo","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R95-20260910","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1093\/hmg\/ddq383","article-title":"Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity","volume":"19","author":"Ferri","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R96-20260910","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/brainsci14111055","article-title":"Gold coast criteria in ALS diagnosis: a real-world experience","volume":"14","author":"Ferullo","year":"2024","journal-title":"Brain Sci"},{"key":"R97-20260910","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamaneurol.2016.3712","article-title":"Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia","volume":"74","author":"Freischmidt","year":"2017","journal-title":"JAMA Neurol"},{"key":"R98-20260910","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrn2786","article-title":"Prion-like mechanisms in neurodegenerative diseases","volume":"11","author":"Frost","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"R99-20260910","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10048-018-0553-9","article-title":"FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy","volume":"19","author":"Funikov","year":"2018","journal-title":"Neurogenetics"},{"key":"R100-20260910","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.4081\/ejtm.2022.10064","article-title":"Involvement of muscle satellite cell dysfunction in neuromuscular disorders: expanding the portfolio of satellite cell-opathies","volume":"32","author":"Ganassi","year":"2022","journal-title":"Eur J Transl Myol"},{"key":"R101-20260910","doi-asserted-by":"crossref","first-page":"a024224","DOI":"10.1101\/cshperspect.a024224","article-title":"Disease mechanisms of C9ORF72 repeat expansions","volume":"8","author":"Gendron","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R102-20260910","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2023.2851","article-title":"Efficacy and safety of ravulizumab, a complement C5 inhibitor, in adults with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"80","author":"Genge","year":"2023","journal-title":"JAMA Neurol"},{"key":"R103-20260910","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nbd.2018.07.027","article-title":"Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases","volume":"119","author":"Genin","year":"2018","journal-title":"Neurobiol Dis"},{"key":"R104-20260910","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/genes14111981","article-title":"Mitochondria, a key target in amyotrophic lateral sclerosis pathogenesis","volume":"14","author":"Genin","year":"2023","journal-title":"Genes"},{"key":"R105-20260910","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/21678421.2024.2372648","article-title":"Quantitative susceptibility mapping in amyotrophic lateral sclerosis: automatic quantification of the magnetic susceptibility in the subcortical nuclei","volume":"26","author":"Ghaderi","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R106-20260910","doi-asserted-by":"crossref","first-page":"a024125","DOI":"10.1101\/cshperspect.a024125","article-title":"Genetics of amyotrophic lateral sclerosis","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R107-20260910","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.3390\/ijms232315218","article-title":"The role of epigenetics in neuroinflammatory-driven diseases","volume":"23","author":"Giallongo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R108-20260910","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/biom11071012","article-title":"Mitostasis, calcium and free radicals in health, aging and neurodegeneration","volume":"11","author":"Godoy","year":"2021","journal-title":"Biomolecules"},{"key":"R109-20260910","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cub.2016.12.038","article-title":"The ER-mitochondria tethering complex VAPB-PTPIP51 regulates autophagy","volume":"27","author":"Gomez-Suaga","year":"2017","journal-title":"Curr Biol"},{"key":"R110-20260910","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7555\/JBR.36.20220009","article-title":"Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis","volume":"36","author":"Gong","year":"2022","journal-title":"J Biomed Res"},{"key":"R111-20260910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010854","article-title":"Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment","volume":"8","author":"Goodall","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"R112-20260910","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.04.008","article-title":"Impaired protein degradation in FTLD and related disorders","volume":"32","author":"G\u00f6tzl","year":"2016","journal-title":"Ageing Res Rev"},{"key":"R113-20260910","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"R114-20260910","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"R115-20260910","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molcel.2019.10.017","article-title":"Core components of the nuclear pore bind distinct states of chromatin and contribute to polycomb repression","volume":"77","author":"Gozalo","year":"2020","journal-title":"Mol Cell"},{"key":"R116-20260910","doi-asserted-by":"crossref","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical spectrum of amyotrophic lateral sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R117-20260910","doi-asserted-by":"crossref","first-page":"eaaw9997","DOI":"10.1126\/science.aaw9997","article-title":"Axonal transport: driving synaptic function","volume":"366","author":"Guedes-Dias","year":"2019","journal-title":"Science"},{"key":"R118-20260910","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pneurobio.2016.09.004","article-title":"TDP-43\/FUS in motor neuron disease: complexity and challenges","volume":"145-146","author":"Guerrero","year":"2016","journal-title":"Prog Neurobiol"},{"key":"R119-20260910","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/acn3.51299","article-title":"Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis","volume":"8","author":"Guo","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R120-20260910","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biology10020163","article-title":"Crosstalk between different DNA repair pathways contributes to neurodegenerative diseases","volume":"10","author":"Gupta","year":"2021","journal-title":"Biology"},{"key":"R121-20260910","doi-asserted-by":"crossref","first-page":"106566","DOI":"10.1016\/j.clineuro.2021.106566","article-title":"The value of serum uric acid as a prognostic biomarker in amyotrophic lateral sclerosis: evidence from a meta-analysis","volume":"203","author":"Haji","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"R122-20260910","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R123-20260910","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1016\/j.molcel.2023.08.005","article-title":"Damaged mitochondria recruit the effector NEMO to activate NF-kappaB signaling","volume":"83","author":"Harding","year":"2023","journal-title":"Mol Cell"},{"key":"R124-20260910","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1111\/febs.16175","article-title":"Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon?","volume":"289","author":"Hartmann","year":"2022","journal-title":"FEBS J"},{"key":"R125-20260910","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cm.21099","article-title":"Dissecting the cellular functions of plant microtubules using mutant tubulins","volume":"70","author":"Hashimoto","year":"2013","journal-title":"Cytoskeleton"},{"key":"R126-20260910","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1007\/s12035-016-0322-4","article-title":"Administration of 17\u03b2-estradiol improves motoneuron survival and down-regulates inflammasome activation in Male SOD1(G93A) ALS mice","volume":"54","author":"Heitzer","year":"2017","journal-title":"Mol Neurobiol"},{"key":"R127-20260910","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1007\/s00018-018-2873-1","article-title":"Dysregulation of a novel miR-1825\/TBCB\/TUBA4A pathway in sporadic and familial ALS","volume":"75","author":"Helferich","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"R128-20260910","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-020-00219-w","article-title":"Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases","volume":"9","author":"Huang","year":"2020","journal-title":"Transl Neurodegener"},{"key":"R129-20260910","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.21037\/qims-24-1297","article-title":"Association of glymphatic system disturbance with neural dysfunction in amyotrophic lateral sclerosis","volume":"15","author":"Huang","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"R130-20260910","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s13760-024-02476-2","article-title":"Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"124","author":"Huang","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"R131-20260910","first-page":"S320","article-title":"Amyotrophic lateral sclerosis: disease state overview","volume":"24","author":"Hulisz","year":"2018","journal-title":"Am J Manag Care"},{"key":"R132-20260910","first-page":"e30639","article-title":"Transactivation response DNA-binding protein of 43 (TDP-43) and glial cell roles in neurological disorders","volume":"14","author":"Hussain","year":"2022","journal-title":"Cureus"},{"key":"R133-20260910","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/hmg\/ddt296","article-title":"RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy","volume":"22","author":"Ihara","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R134-20260910","doi-asserted-by":"crossref","first-page":"996061","DOI":"10.3389\/fcell.2022.996061","article-title":"Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10\u2013what distinguishes the two?","volume":"10","author":"Ikeda","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R135-20260910","doi-asserted-by":"crossref","first-page":"e075037","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"Br Med J"},{"key":"R136-20260910","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol Res"},{"key":"R137-20260910","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.aaf6803","article-title":"RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS","volume":"353","author":"Ito","year":"2016","journal-title":"Science"},{"key":"R138-20260910","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00234-025-03629-7","article-title":"Mapping motor and extra-motor gray and white matter changes in ALS: a comprehensive review of MRI insights","volume":"67","author":"Iuzzolino","year":"2025","journal-title":"Neuroradiology"},{"key":"R139-20260910","doi-asserted-by":"crossref","first-page":"115525","DOI":"10.1016\/j.addr.2025.115525","article-title":"Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases","volume":"218","author":"Izrael","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"R140-20260910","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med Res Rev"},{"key":"R141-20260910","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00702-024-02850-7","article-title":"Mild cognitive impairment in amyotrophic lateral sclerosis: current view","volume":"132","author":"Jellinger","year":"2025","journal-title":"J Neural Transm"},{"key":"R142-20260910","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00702-024-02841-8","article-title":"The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view","volume":"132","author":"Jellinger","year":"2025","journal-title":"J Neural Transm"},{"key":"R143-20260910","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB reports"},{"key":"R144-20260910","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12035-024-04269-3","article-title":"The current potential pathogenesis of amyotrophic lateral sclerosis","volume":"62","author":"Jiang","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R145-20260910","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"key":"R146-20260910","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuro.2012.04.001","article-title":"Pesticide exposure and amyotrophic lateral sclerosis","volume":"33","author":"Kamel","year":"2012","journal-title":"Neurotoxicology"},{"key":"R147-20260910","doi-asserted-by":"crossref","first-page":"1105247","DOI":"10.3389\/fncel.2023.1105247","article-title":"The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation","volume":"17","author":"Karvandi","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"R148-20260910","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"R149-20260910","doi-asserted-by":"crossref","first-page":"114378","DOI":"10.1016\/j.biopha.2023.114378","article-title":"Masitinib: The promising actor in the next season of the amyotrophic lateral sclerosis treatment series","volume":"160","author":"Ketabforoush","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R150-20260910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"key":"R151-20260910","doi-asserted-by":"crossref","first-page":"e0247025","DOI":"10.1371\/journal.pone.0247025","article-title":"Amyotrophic lateral sclerosis (ALS) prediction model derived from plasma and CSF biomarkers","volume":"16","author":"Khosla","year":"2021","journal-title":"PLoS One"},{"key":"R152-20260910","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"R153-20260910","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/17482968.2012.674140","article-title":"An increase in ALS incidence on the Kii Peninsula, 1960\u20132009: a possible link to change in drinking water source","volume":"13","author":"Kihira","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"R154-20260910","doi-asserted-by":"crossref","first-page":"111508","DOI":"10.1016\/j.celrep.2022.111508","article-title":"Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2","volume":"41","author":"Kim","year":"2022","journal-title":"Cell Rep"},{"key":"R155-20260910","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","article-title":"Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS","volume":"495","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"R156-20260910","doi-asserted-by":"crossref","first-page":"14263","DOI":"10.1074\/jbc.M114.561902","article-title":"The RNA-binding protein TDP-43 selectively disrupts microRNA-1\/206 incorporation into the RNA-induced silencing complex","volume":"289","author":"King","year":"2014","journal-title":"J Biol Chem"},{"key":"R157-20260910","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1007\/s12035-022-02934-z","article-title":"Recent updates on the genetics of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"59","author":"Kirola","year":"2022","journal-title":"Mol Neurobiol"},{"key":"R158-20260910","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1007\/s00018-021-03872-0","article-title":"DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity","volume":"78","author":"Kok","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R159-20260910","doi-asserted-by":"crossref","first-page":"786420","DOI":"10.3389\/fnagi.2022.786420","article-title":"DNA damage, defective DNA repair, and neurodegeneration in amyotrophic lateral sclerosis","volume":"14","author":"Konopka","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R160-20260910","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat Med"},{"key":"R161-20260910","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-021-03214-x","article-title":"Function and regulation of the divisome for mitochondrial fission","volume":"590","author":"Kraus","year":"2021","journal-title":"Nature"},{"key":"R162-20260910","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1248\/bpb.b24-00418","article-title":"MicroRNA-5572 is associated with endoplasmic reticulum stress responses in low zinc treated and SOD1 G85R-transfected HEK293 cells","volume":"47","author":"Kurita","year":"2024","journal-title":"Biol Pharm Bull"},{"key":"R163-20260910","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"R164-20260910","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"R165-20260910","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/acs.chemrestox.2c00057","article-title":"Cytochromes P450 2C8 and 3A catalyze the metabolic activation of the tyrosine kinase inhibitor masitinib","volume":"35","author":"Latham","year":"2022","journal-title":"Chem Res Toxicol"},{"key":"R166-20260910","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/humu.22319","article-title":"TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update","volume":"34","author":"Lattante","year":"2013","journal-title":"Hum Mutat"},{"key":"R167-20260910","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.expneurol.2013.03.027","article-title":"Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons","volume":"247","author":"Lautenschl\u00e4ger","year":"2013","journal-title":"Exp Neurol"},{"key":"R168-20260910","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41593-021-00944-z","article-title":"Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS","volume":"24","author":"Lee","year":"2021","journal-title":"Nat Neurosci"},{"key":"R169-20260910","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.26329","article-title":"Imaging net retrograde axonal transport in vivo: a physiological biomarker","volume":"91","author":"Lee","year":"2022","journal-title":"Ann Neurol"},{"key":"R170-20260910","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7150\/ijbs.16158","article-title":"Changes in the expression of FUS\/TLS in spinal cords of SOD1 G93A transgenic mice and correlation with motor-neuron degeneration","volume":"12","author":"Li","year":"2016","journal-title":"Int J Biol Sci"},{"key":"R171-20260910","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s13311-022-01233-8","article-title":"Retroviral elements in pathophysiology and as therapeutic targets for amyotrophic lateral sclerosis","volume":"19","author":"Li","year":"2022","journal-title":"Neurotherapeutics"},{"key":"R172-20260910","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21678421.2019.1582668","article-title":"Identification and functional analysis of novel mutations in the SOD1 gene in Chinese patients with amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R173-20260910","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41467-025-57135-8","article-title":"Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"R174-20260910","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"R175-20260910","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.omtn.2022.04.007","article-title":"Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD","volume":"28","author":"Liu","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"R176-20260910","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","article-title":"Poly(GR) in C9ORF72-related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons","volume":"92","author":"Lopez-Gonzalez","year":"2016","journal-title":"Neuron"},{"key":"R177-20260910","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3390\/cimb45040217","article-title":"Role of oxidative stress on the etiology and pathophysiology of amyotrophic lateral sclerosis (ALS) and its relation with the enteric nervous system","volume":"45","author":"L\u00f3pez-Pingarr\u00f3n","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"R178-20260910","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.7150\/ijbs.15938","article-title":"The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Lu","year":"2016","journal-title":"Int J Biol Sci"},{"key":"R179-20260910","doi-asserted-by":"crossref","first-page":"753870","DOI":"10.3389\/fnins.2021.753870","article-title":"Potential common genetic risks of sporadic parkinson\u2019s disease and amyotrophic lateral sclerosis in the han population of mainland China","volume":"15","author":"Lu","year":"2021","journal-title":"Front Neurosci"},{"key":"R180-20260910","doi-asserted-by":"crossref","first-page":"17562864251313915","DOI":"10.1177\/17562864251313915","article-title":"Tofersen and other antisense oligonucleotides in ALS","volume":"18","author":"Ludolph","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"R181-20260910","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3390\/ijms21197174","article-title":"Melatonin and autophagy in aging-related neurodegenerative diseases","volume":"21","author":"Luo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R182-20260910","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.37765\/ajmc.2023.89389","article-title":"Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life","volume":"29","author":"Lynch","year":"2023","journal-title":"Am J Manag Care"},{"key":"R183-20260910","doi-asserted-by":"crossref","first-page":"e028486","DOI":"10.1136\/bmjopen-2018-028486","article-title":"Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)","volume":"9","author":"Mandrioli","year":"2019","journal-title":"BMJ Open"},{"key":"R184-20260910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.04.005","article-title":"Optineurin in amyotrophic lateral sclerosis: multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms","volume":"154","author":"Markovinovic","year":"2017","journal-title":"Prog Neurobiol"},{"key":"R185-20260910","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s10020-024-00942-4","article-title":"Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death","volume":"30","author":"Mart\u00ednez","year":"2024","journal-title":"Mol Med"},{"key":"R186-20260910","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"R187-20260910","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2013.02.099","article-title":"Tespa1 is a novel component of mitochondria-associated endoplasmic reticulum membranes and affects mitochondrial calcium flux","volume":"433","author":"Matsuzaki","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R188-20260910","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14712598.2016.1116516","article-title":"Stem cells therapy for ALS","volume":"16","author":"Mazzini","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"R189-20260910","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14737175.2019.1623026","article-title":"Gut microbiota in ALS: possible role in pathogenesis?","volume":"19","author":"McCombe","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"R190-20260910","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochimica Et Biophysica Acta Proteins and Proteomics"},{"key":"R191-20260910","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","article-title":"CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro","volume":"13","author":"Meijboom","year":"2022","journal-title":"Nat Commun"},{"key":"R192-20260910","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci"},{"key":"R193-20260910","doi-asserted-by":"crossref","first-page":"1530719","DOI":"10.3389\/fmmed.2025.1530719","article-title":"Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis","volume":"5","author":"Mengistu","year":"2025","journal-title":"Front Mol Med"},{"key":"R194-20260910","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.27818","article-title":"Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: treatment experience in clinical practice","volume":"67","author":"Meyer","year":"2023","journal-title":"Muscle Nerve"},{"key":"R195-20260910","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R196-20260910","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"R197-20260910","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1474-4422(24)00517-9","article-title":"Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications","volume":"24","author":"Moens","year":"2025","journal-title":"Lancet Neurol"},{"key":"R198-20260910","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1038\/s41598-023-38875-3","article-title":"Neuroimmune characterization of optineurin insufficiency mouse model during ageing","volume":"13","author":"Mohovic","year":"2023","journal-title":"Sci Rep"},{"key":"R199-20260910","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1093\/hmg\/ddx348","article-title":"Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels","volume":"26","author":"Moller","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R200-20260910","doi-asserted-by":"crossref","first-page":"7070469","DOI":"10.1155\/2017\/7070469","article-title":"Neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets","volume":"2017","author":"Morello","year":"2017","journal-title":"Mediators Inflamm"},{"key":"R201-20260910","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/B978-0-323-98817-9.00027-2","article-title":"Novel therapeutic approaches for motor neuron disease","volume":"196","author":"Muzio","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"R202-20260910","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s13760-021-01753-8","article-title":"Statins and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"122","author":"Nabizadeh","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"R203-20260910","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-1-0716-1990-2_27","article-title":"Imaging intracellular trafficking in neurons of C. elegans","volume":"2431","author":"Nadiminti","year":"2022","journal-title":"Methods Mol Biol"},{"key":"R204-20260910","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1038\/s41598-018-33964-0","article-title":"Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity","volume":"8","author":"Nakaya","year":"2018","journal-title":"Sci Rep"},{"key":"R205-20260910","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13063-022-06327-4","article-title":"Efficacy and safety of Lenzumestrocel (Neuronata-R\u00ae inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial","volume":"23","author":"Nam","year":"2022","journal-title":"Trials"},{"key":"R206-20260910","doi-asserted-by":"crossref","first-page":"1148444","DOI":"10.3389\/fnagi.2023.1148444","article-title":"Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R: lenzumestrocel) treatment in ALS: propensity-score-matched control, surveillance study","volume":"15","author":"Nam","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"R207-20260910","doi-asserted-by":"crossref","first-page":"103834","DOI":"10.1016\/j.mcn.2023.103834","article-title":"Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1","volume":"125","author":"Nemtsova","year":"2023","journal-title":"Mol Cell Neurosci"},{"key":"R208-20260910","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"R209-20260910","doi-asserted-by":"crossref","first-page":"152504","DOI":"10.1016\/j.scitotenv.2021.152504","article-title":"Systematic and state-of the science review of the role of environmental factors in amyotrophic lateral sclerosis (ALS) or Lou Gehrig\u2019s disease","volume":"817","author":"Newell","year":"2022","journal-title":"Sci Total Environ"},{"key":"R210-20260910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2011.01.031","article-title":"Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 mice","volume":"42","author":"Nguyen","year":"2011","journal-title":"Neurobiol Dis"},{"key":"R211-20260910","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","article-title":"Ageing as a risk factor for ALS\/FTD","volume":"26","author":"Niccoli","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R212-20260910","doi-asserted-by":"crossref","first-page":"111821","DOI":"10.1016\/j.mad.2023.111821","article-title":"Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: a narrative review","volume":"212","author":"Nicoletti","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"R213-20260910","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clinph.2011.05.030","article-title":"Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset","volume":"123","author":"Noto","year":"2012","journal-title":"Clin Neurophysiol"},{"key":"R214-20260910","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12883-021-02288-4","article-title":"Increased cerebrospinal fluid adenosine 5\u2019-triphosphate in patients with amyotrophic lateral sclerosis","volume":"21","author":"Nukui","year":"2021","journal-title":"BMC Neurol"},{"key":"R215-20260910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","article-title":"TBK1: a new player in ALS linking autophagy and neuroinflammation","volume":"10","author":"Oakes","year":"2017","journal-title":"Mol Brain"},{"key":"R216-20260910","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/brain\/awae039","article-title":"How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?","volume":"147","author":"Odierna","year":"2024","journal-title":"Brain"},{"key":"R217-20260910","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14737175.2024.2355983","article-title":"Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis","volume":"24","author":"Oliveira Santos","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"R218-20260910","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"R219-20260910","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/nmt-2021-0042","article-title":"MN-166 (ibudilast) in amyotrophic lateral sclerosis in a phase IIb\/III study: COMBAT\u2013ALS study design","volume":"11","author":"Oskarsson","year":"2021","journal-title":"Neurodegener Dis Manag"},{"key":"R220-20260910","doi-asserted-by":"crossref","first-page":"e2459058","DOI":"10.1001\/jamanetworkopen.2024.59058","article-title":"Efficacy and safety of zilucoplan in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"8","author":"Paganoni","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R221-20260910","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2202-12-24","article-title":"Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease","volume":"12","author":"Palmisano","year":"2011","journal-title":"BMC Neurosci"},{"key":"R222-20260910","doi-asserted-by":"crossref","first-page":"3402753","DOI":"10.1155\/2021\/3402753","article-title":"Evidence-based research strategy of traditional Chinese medicine for amyotrophic lateral sclerosis","volume":"2021","author":"Pan","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R223-20260910","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/ijms19051345","article-title":"SOD1 in amyotrophic lateral sclerosis: \u201cambivalent\u201d behavior connected to the disease","volume":"19","author":"Pansarasa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R224-20260910","doi-asserted-by":"crossref","first-page":"RP88826","DOI":"10.7554\/eLife.88826.3","article-title":"Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4\/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice","volume":"12","author":"Papazian","year":"2024","journal-title":"Elife"},{"key":"R225-20260910","doi-asserted-by":"crossref","first-page":"e1004469","DOI":"10.1371\/journal.pmed.1004469","article-title":"Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: a phase 2A clinical trial","volume":"21","author":"Perrin","year":"2024","journal-title":"PLoS Med"},{"key":"R226-20260910","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1097\/MS9.0000000000002332","article-title":"Diffusion tensor imaging biomarkers and clinical assessments in amyotrophic lateral sclerosis (ALS) patients: an exploratory study","volume":"86","author":"Pezeshgi","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"R227-20260910","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain"},{"key":"R228-20260910","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/molecules26040953","article-title":"The role of the inflammasome in neurodegenerative diseases","volume":"26","author":"Piancone","year":"2021","journal-title":"Molecules"},{"key":"R229-20260910","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1042\/EBC20210024","article-title":"RNA-binding protein dysfunction in neurodegeneration","volume":"65","author":"Popper","year":"2021","journal-title":"Essays Biochem"},{"key":"R230-20260910","doi-asserted-by":"crossref","first-page":"658","DOI":"10.14336\/AD.2024.0286","article-title":"Amyloid-\u03b2 and phosphorylated tau are the key biomarkers and predictors of Alzheimer\u2019s disease","volume":"16","author":"Pradeepkiran","year":"2024","journal-title":"Aging Dis"},{"key":"R231-20260910","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/15476286.2020.1809186","article-title":"RNA-binding proteins in neurological development and disease","volume":"18","author":"Prashad","year":"2021","journal-title":"RNA Biol"},{"key":"R232-20260910","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/glia.22755","article-title":"Zebrafish as a model to investigate CNS myelination","volume":"63","author":"Preston","year":"2015","journal-title":"Glia"},{"key":"R233-20260910","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.clinph.2021.08.014","article-title":"Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis","volume":"132","author":"Pugdahl","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"R234-20260910","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbi.2024.08.044","article-title":"Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis","volume":"122","author":"Pupillo","year":"2024","journal-title":"Brain Behav Immun"},{"key":"R235-20260910","doi-asserted-by":"crossref","first-page":"28110","DOI":"10.1038\/s41598-024-79511-y","article-title":"Identifying amyotrophic lateral sclerosis using diffusion tensor imaging, and correlation with neurofilament markers","volume":"14","author":"Qin","year":"2024","journal-title":"Sci Rep"},{"key":"R236-20260910","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells10030565","article-title":"Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: mechanisms and therapeutic perspectives","volume":"10","author":"Raffaele","year":"2021","journal-title":"Cells"},{"key":"R237-20260910","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11658-022-00359-z","article-title":"Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects","volume":"27","author":"Rahbaran","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"R238-20260910","doi-asserted-by":"crossref","first-page":"119857","DOI":"10.1016\/j.cca.2024.119857","article-title":"Biomarkers in Alzheimer\u2019s disease","volume":"562","author":"Rajendran","year":"2024","journal-title":"Clin Chim Acta"},{"key":"R239-20260910","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jnc.15373","article-title":"Nuclear lipidome is altered in amyotrophic lateral sclerosis: a pilot study","volume":"158","author":"Ram\u00edrez-Nu\u00f1ez","year":"2021","journal-title":"J Neurochem"},{"key":"R240-20260910","doi-asserted-by":"crossref","first-page":"17583","DOI":"10.1038\/s41598-025-02167-9","article-title":"Stress exposure affects amyotrophic lateral sclerosis pathogenesis via PI3K\/Akt and focal adhesion pathways: evidence from three experimental models","volume":"15","author":"Ras\u00e0","year":"2025","journal-title":"Sci Rep"},{"key":"R241-20260910","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/21678421.2019.1612435","article-title":"Clinical characteristics of a large cohort of US participants enrolled in the National amyotrophic lateral sclerosis (ALS) registry, 2010\u20132015","volume":"20","author":"Raymond","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R242-20260910","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lfs.2017.06.009","article-title":"Gene networks in neurodegenerative disorders","volume":"183","author":"Recabarren","year":"2017","journal-title":"Life Sci"},{"key":"R243-20260910","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res Rev"},{"key":"R244-20260910","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","article-title":"Progranulin as a therapeutic target in neurodegenerative diseases","volume":"43","author":"Rhinn","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"R245-20260910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nrl.2015.12.001","article-title":"Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis","volume":"34","author":"Riancho","year":"2019","journal-title":"Neurologia"},{"key":"R246-20260910","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00484-020-01896-y","article-title":"The role of magnetic fields in neurodegenerative diseases","volume":"65","author":"Riancho","year":"2021","journal-title":"Int J Biometeorol"},{"key":"R247-20260910","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.3390\/ijms25189966","article-title":"Understanding amyotrophic lateral sclerosis: pathophysiology, diagnosis, and therapeutic advances","volume":"25","author":"Rizea","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R248-20260910","doi-asserted-by":"crossref","first-page":"135813","DOI":"10.1016\/j.neulet.2021.135813","article-title":"Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis","volume":"750","author":"Robichaud","year":"2021","journal-title":"Neurosci Lett"},{"key":"R249-20260910","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/bs.pmbts.2020.03.009","article-title":"Autophagy in motor neuron diseases","volume":"172","author":"Rodr\u00edguez-Muela","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"key":"R250-20260910","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuroscience.2008.09.055","article-title":"Neuron-specific overexpression of the co-chaperone Bcl-2-associated athanogene-1 in superoxide dismutase 1(G93A)-transgenic mice","volume":"157","author":"Rohde","year":"2008","journal-title":"Neuroscience"},{"key":"R251-20260910","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/1087057113497256","article-title":"Targeting RNA binding proteins involved in neurodegeneration","volume":"18","author":"Romano","year":"2013","journal-title":"J Biomol Screen"},{"key":"R252-20260910","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-319-55769-4_6","article-title":"EAAT2 and the molecular signature of amyotrophic lateral sclerosis","volume":"16","author":"Rosenblum","year":"2017","journal-title":"Adv Neurobiol"},{"key":"R253-20260910","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10 Suppl","author":"Ross","year":"2004","journal-title":"Nat Med"},{"key":"R254-20260910","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/bpa.12355","article-title":"Old versus new mechanisms in the pathogenesis of ALS","volume":"26","author":"Rossi","year":"2016","journal-title":"Brain Pathol"},{"key":"R255-20260910","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","article-title":"Edaravone: a new drug approved for ALS","volume":"171","author":"Rothstein","year":"2017","journal-title":"Cell"},{"key":"R256-20260910","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-025-00851-y","article-title":"RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights","volume":"20","author":"Rummens","year":"2025","journal-title":"Mol Neurodegener"},{"key":"R257-20260910","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/molecules30061211","article-title":"Emerging ferroptosis involvement in amyotrophic lateral sclerosis pathogenesis: neuroprotective activity of polyphenols","volume":"30","author":"Russo","year":"2025","journal-title":"Molecules"},{"key":"R258-20260910","doi-asserted-by":"crossref","first-page":"102061","DOI":"10.1016\/j.isci.2021.102061","article-title":"Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology","volume":"24","author":"Ryan","year":"2021","journal-title":"iScience"},{"key":"R259-20260910","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1080\/07391102.2022.2090441","article-title":"Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis","volume":"41","author":"Sai Swaroop","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"R260-20260910","doi-asserted-by":"crossref","first-page":"e13078","DOI":"10.1111\/bpa.13078","article-title":"Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"32","author":"Salvany","year":"2022","journal-title":"Brain Pathol"},{"key":"R261-20260910","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jocn.2021.05.017","article-title":"The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis","volume":"89","author":"Sarraf","year":"2021","journal-title":"J Clin Neurosci"},{"key":"R262-20260910","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddm110","article-title":"Mutation of SOD1 in ALS: a gain of a loss of function","volume":"16","author":"Sau","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R263-20260910","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3390\/ijms22052422","article-title":"The ALS-associated FUS (P525L) variant does not directly interfere with microtubule-dependent kinesin-1 motility","volume":"22","author":"Seifert","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R264-20260910","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.4103\/NRR.NRR-D-24-00694","article-title":"Oligodendroglial heterogeneity in health, disease, and recovery: deeper insights into myelin dynamics","volume":"20","author":"Serneels","year":"2025","journal-title":"Neural Regen Res"},{"key":"R265-20260910","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/BST20221365","article-title":"CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy","volume":"51","author":"Shammas","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"R266-20260910","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11064-015-1779-7","article-title":"Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces mitochondrial and lysosomal dysfunction","volume":"41","author":"Sharma","year":"2016","journal-title":"Neurochem Res"},{"key":"R267-20260910","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4103\/1673-5374.208564","article-title":"The interaction of genetics and environmental toxicants in amyotrophic lateral sclerosis: results from animal models","volume":"12","author":"Sher","year":"2017","journal-title":"Neural Regen Res"},{"key":"R268-20260910","doi-asserted-by":"crossref","first-page":"e127736","DOI":"10.1172\/jci.insight.127736","article-title":"Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons","volume":"5","author":"Shi","year":"2019","journal-title":"JCI Insight"},{"key":"R269-20260910","first-page":"4086","article-title":"Long-term survival of a patient with amyotrophic lateral sclerosis (ALS) who received autologous adipose-derived mesenchymal stem cells","volume":"25","author":"Shigematsu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R270-20260910","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinph.2024.03.015","article-title":"Neurophysiological and imaging biomarkers of lower motor neuron dysfunction in motor neuron diseases\/amyotrophic lateral sclerosis: IFCN handbook chapter","volume":"162","author":"Shin-Yi Lin","year":"2024","journal-title":"Clin Neurophysiol"},{"key":"R271-20260910","doi-asserted-by":"crossref","first-page":"EVIDoa2400249","DOI":"10.1056\/EVIDoa2400249","article-title":"Clinical safety and preliminary efficacy of regulatory T cells for ALS","volume":"4","author":"Shneider","year":"2025","journal-title":"NEJM Evid"},{"key":"R272-20260910","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.1038\/s41598-021-91496-6","article-title":"FGF23, a novel muscle biomarker detected in the early stages of ALS","volume":"11","author":"Si","year":"2021","journal-title":"Sci Rep"},{"key":"R273-20260910","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"key":"R274-20260910","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci Lett"},{"key":"R275-20260910","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0369-19.2020","article-title":"Synaptic actions of amyotrophic lateral sclerosis-associated G85R-SOD1 in the squid giant synapse","volume":"7","author":"Song","year":"2020","journal-title":"eNeuro"},{"key":"R276-20260910","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat Neurosci"},{"key":"R277-20260910","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1523\/JNEUROSCI.0562-23.2023","article-title":"ALS-associated KIF5A mutation causes locomotor deficits associated with cytoplasmic inclusions, alterations of neuromuscular junctions, and motor neuron loss","volume":"43","author":"Soustelle","year":"2023","journal-title":"J Neurosci"},{"key":"R278-20260910","doi-asserted-by":"crossref","first-page":"117185","DOI":"10.1016\/j.jns.2020.117185","article-title":"Western pacific ALS-PDC: evidence implicating cycad genotoxins","volume":"419","author":"Spencer","year":"2020","journal-title":"J Neurol Sci"},{"key":"R279-20260910","doi-asserted-by":"crossref","first-page":"103900","DOI":"10.1016\/j.isci.2022.103900","article-title":"Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology","volume":"25","author":"Sprunger","year":"2022","journal-title":"iScience"},{"key":"R280-20260910","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.3390\/ijms26083854","article-title":"Neuroinflammation and amyotrophic lateral sclerosis: recent advances in anti-inflammatory cytokines as therapeutic strategies","volume":"26","author":"Stacchiotti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R281-20260910","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-510X(00)00351-8","article-title":"Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis","volume":"177","author":"Stieber","year":"2000","journal-title":"J Neurol Sci"},{"key":"R282-20260910","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1038\/ncomms4996","article-title":"ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS\/FTD-associated TDP-43","volume":"5","author":"Stoica","year":"2014","journal-title":"Nat Commun"},{"key":"R283-20260910","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.15252\/embr.201541726","article-title":"ALS\/FTD-associated FUS activates GSK-3\u03b2 to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations","volume":"17","author":"Stoica","year":"2016","journal-title":"EMBO Rep"},{"key":"R284-20260910","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mus.24198","article-title":"Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research","volume":"49","author":"Su","year":"2014","journal-title":"Muscle Nerve"},{"key":"R285-20260910","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/21678421.2016.1259334","article-title":"Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis","volume":"18","author":"Sufit","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R286-20260910","doi-asserted-by":"crossref","first-page":"112025","DOI":"10.1016\/j.celrep.2023.112025","article-title":"FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration","volume":"42","author":"Szewczyk","year":"2023","journal-title":"Cell Rep"},{"key":"R287-20260910","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.bbagen.2014.08.012","article-title":"Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis","volume":"1840","author":"Tagashira","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"R288-20260910","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.7150\/ijbs.16696","article-title":"Distributed features of vimentin-containing neural precursor cells in olfactory bulb of SOD1G93A transgenic mice: a study about resource of endogenous neural stem cells","volume":"12","author":"Tang","year":"2016","journal-title":"Int J Biol Sci"},{"key":"R289-20260910","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.7150\/ijbs.33461","article-title":"Altered features of vimentin-containing cells in cerebrum of Tg(SOD1*G93A)1Gur mice: a preliminary study on cerebrum endogenous neural precursor cells in amyotrophic lateral sclerosis","volume":"15","author":"Tang","year":"2019","journal-title":"Int J Biol Sci"},{"key":"R290-20260910","doi-asserted-by":"crossref","first-page":"e138207","DOI":"10.1172\/JCI138207","article-title":"Reduction of nemo-like kinase increases lysosome biogenesis and ameliorates TDP-43\u2013related neurodegeneration","volume":"133","author":"Tejwani","year":"2023","journal-title":"J Clin Invest"},{"key":"R291-20260910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11910-016-0658-1","article-title":"ALS: Recent developments from genetics studies","volume":"16","author":"Therrien","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R292-20260910","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/acn3.70001","article-title":"ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression","volume":"12","author":"Thomas","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"R293-20260910","doi-asserted-by":"crossref","first-page":"e200019","DOI":"10.1212\/NXI.0000000000200019","article-title":"Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis","volume":"9","author":"Thonhoff","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R294-20260910","doi-asserted-by":"crossref","first-page":"1415106","DOI":"10.3389\/fneur.2024.1415106","article-title":"A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis","volume":"15","author":"Thonhoff","year":"2024","journal-title":"Front Neurol"},{"key":"R295-20260910","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/187152710791292585","article-title":"Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage","volume":"9","author":"Ticozzi","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R296-20260910","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.3390\/ijms26115240","article-title":"Amyotrophic lateral sclerosis: pathophysiological mechanisms and treatment strategies (part 2)","volume":"26","author":"Tolochko","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R297-20260910","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jnc.15529","article-title":"Proteostasis deregulation as a driver of C9ORF72 pathogenesis","volume":"159","author":"Torres","year":"2021","journal-title":"J Neurochem"},{"key":"R298-20260910","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/15384101.2021.1886661","article-title":"Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death","volume":"20","author":"Tsai","year":"2021","journal-title":"Cell Cycle"},{"key":"R299-20260910","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s12031-023-02169-0","article-title":"Role of senataxin in amyotrophic lateral sclerosis","volume":"73","author":"Tsui","year":"2023","journal-title":"J Mol Neurosci"},{"key":"R300-20260910","doi-asserted-by":"crossref","first-page":"e70133","DOI":"10.1002\/jbt.70133","article-title":"Oxidative\/nitrosative stress, apoptosis, and redox signaling: key players in neurodegenerative diseases","volume":"39","author":"\u00dcremi\u015f","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"key":"R301-20260910","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-4547(20010301)63:5<377::AID-JNR1032>3.0.CO;2-#","article-title":"N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx","volume":"63","author":"Urushitani","year":"2001","journal-title":"J Neurosci Res"},{"key":"R302-20260910","doi-asserted-by":"crossref","first-page":"130772","DOI":"10.1016\/j.bbagen.2025.130772","article-title":"The roles of intrinsically disordered proteins in neurodegeneration","volume":"1869","author":"Utami","year":"2025","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"R303-20260910","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1474-4422(24)00216-3","article-title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study","volume":"23","author":"van den Berg","year":"2024","journal-title":"Lancet Neurol"},{"key":"R304-20260910","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3390\/ijms20112818","article-title":"Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques","volume":"20","author":"Van Den Bos","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R305-20260910","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.22611","article-title":"Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis","volume":"70","author":"Van Es","year":"2011","journal-title":"Ann Neurol"},{"key":"R306-20260910","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic Lateral Sclerosis","volume":"390","author":"Van Es","year":"2017","journal-title":"Lancet"},{"key":"R307-20260910","first-page":"1","article-title":"Amyotrophic lateral sclerosis; clinical features, differential diagnosis and pathology","volume":"176","author":"Van Es","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"R308-20260910","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-031-75980-2_3","article-title":"Epigenetics in neurodegenerative diseases","volume":"108","author":"van Zundert","year":"2025","journal-title":"Subcell Biochem"},{"key":"R309-20260910","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.3390\/ijms222212175","article-title":"The role of nucleocytoplasmic transport defects in amyotrophic lateral sclerosis","volume":"22","author":"Vanneste","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R310-20260910","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","article-title":"Propagation of protein aggregation in neurodegenerative diseases","volume":"88","author":"Vaquer-Alicea","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"R311-20260910","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/acn3.51446","article-title":"Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study","volume":"8","author":"Vucic","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R312-20260910","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1007\/s00415-024-12485-z","article-title":"Aberrant protein aggregation in amyotrophic lateral sclerosis","volume":"271","author":"Wang","year":"2024","journal-title":"J Neurol"},{"key":"R313-20260910","doi-asserted-by":"crossref","first-page":"e105534","DOI":"10.1371\/journal.pone.0105534","article-title":"Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS-A systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"R314-20260910","doi-asserted-by":"crossref","first-page":"e1007947","DOI":"10.1371\/journal.pgen.1007947","article-title":"TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Genet"},{"key":"R315-20260910","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/15548627.2022.2063003","article-title":"Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1\/sigma-1 receptor chaperone by pridopidine","volume":"19","author":"Wang","year":"2023","journal-title":"Autophagy"},{"key":"R316-20260910","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","article-title":"C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab"},{"key":"R317-20260910","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/ijms25010131","article-title":"Lipids as emerging biomarkers in neurodegenerative diseases","volume":"25","author":"Wei","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R318-20260910","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnmol.2019.00271","article-title":"Prionoid proteins in the pathogenesis of neurodegenerative diseases","volume":"12","author":"Wells","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"R319-20260910","doi-asserted-by":"crossref","first-page":"103505","DOI":"10.1016\/j.nicl.2023.103505","article-title":"Structural and microstructural neuroimaging signature of C9orf72-associated ALS: a multiparametric MRI study","volume":"39","author":"Wiesenfarth","year":"2023","journal-title":"Neuroimage Clin"},{"key":"R320-20260910","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R321-20260910","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp-2022-330504","article-title":"UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target","volume":"94","author":"Willemse","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R322-20260910","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ana.27054","article-title":"Population-based evidence for the use of serum neurofilaments as individual diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis","volume":"96","author":"Witzel","year":"2024","journal-title":"Ann Neurol"},{"key":"R323-20260910","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1038\/ncomms15558","article-title":"Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity","volume":"8","author":"Woo","year":"2017","journal-title":"Nat Commun"},{"key":"R324-20260910","doi-asserted-by":"crossref","first-page":"135553","DOI":"10.1016\/j.neulet.2020.135553","article-title":"Novel SOD1 monoclonal antibodies against the electrostatic loop preferentially detect misfolded SOD1 aggregates","volume":"742","author":"Xia","year":"2021","journal-title":"Neurosci Lett"},{"key":"R325-20260910","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jmg-2024-109978","article-title":"Genetic and clinical analysis of OPTN in amyotrophic lateral sclerosis","volume":"62","author":"Xiao","year":"2025","journal-title":"J Med Genet"},{"key":"R326-20260910","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijdevneu.2008.06.002","article-title":"Nestin-positive cells in the spinal cord: a potential source of neural stem cells","volume":"26","author":"Xu","year":"2008","journal-title":"Int J Dev Neurosci"},{"key":"R327-20260910","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jnr.22263","article-title":"Description of distributed features of the nestin-containing cells in brains of adult mice: a potential source of neural precursor cells","volume":"88","author":"Xu","year":"2010","journal-title":"J Neurosci Res"},{"key":"R328-20260910","doi-asserted-by":"crossref","first-page":"2422572","DOI":"10.1080\/07853890.2024.2422572","article-title":"Overview of nomenclature and diagnosis of amyotrophic lateral sclerosis","volume":"56","author":"Xu","year":"2024","journal-title":"Ann Med"},{"key":"R329-20260910","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4103\/1673-5374.306065","article-title":"Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis","volume":"16","author":"Xu","year":"2021","journal-title":"Neural Regen Res"},{"key":"R330-20260910","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10571-020-00993-1","article-title":"Nerve growth factor is a potential treated target in Tg(SOD1*G93A)1Gur mice","volume":"42","author":"Xu","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"R331-20260910","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1515\/revneuro-2024-0037","article-title":"Current potential diagnostic biomarkers of amyotrophic lateral sclerosis","volume":"35","author":"Xu","year":"2024","journal-title":"Rev Neurosci"},{"key":"R332-20260910","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2018.00063","article-title":"Enteroviral infection: the forgotten link to amyotrophic lateral sclerosis?","volume":"11","author":"Xue","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"R333-20260910","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","article-title":"Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice","volume":"105","author":"Yamanaka","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R334-20260910","doi-asserted-by":"crossref","first-page":"E6209","DOI":"10.1073\/pnas.1605964113","article-title":"Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R335-20260910","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.neuron.2009.02.010","article-title":"Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1","volume":"61","author":"Yang","year":"2009","journal-title":"Neuron"},{"key":"R336-20260910","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/jnc.13575","article-title":"Walking the tightrope: proteostasis and neurodegenerative disease","volume":"137","author":"Yerbury","year":"2016","journal-title":"J Neurochem"},{"key":"R337-20260910","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.exer.2015.06.029","article-title":"Optineurin: the autophagy connection","volume":"144","author":"Ying","year":"2016","journal-title":"Exp Eye Res"},{"key":"R338-20260910","doi-asserted-by":"crossref","first-page":"2399962","DOI":"10.1080\/07853890.2024.2399962","article-title":"Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis","volume":"56","author":"Yuan","year":"2024","journal-title":"Ann Med"},{"key":"R339-20260910","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1007\/s12035-024-04682-8","article-title":"Neural stem\/progenitor cell therapy in patients and animals with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"62","author":"Zhang","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R340-20260910","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biocel.2014.02.018","article-title":"Ubiquilin 2: a component of the ubiquitin\u2013proteasome system with an emerging role in neurodegeneration","volume":"50","author":"Zhang","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"R341-20260910","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R342-20260910","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2013.03.008","article-title":"Melatonin inhibits the caspase-1\/cytochrome c\/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"55","author":"Zhang","year":"2013","journal-title":"Neurobiol Dis"},{"key":"R343-20260910","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11064-015-1750-7","article-title":"Treatment with hydrogen-rich saline delays disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"41","author":"Zhang","year":"2016","journal-title":"Neurochem Res"},{"key":"R344-20260910","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/cells11132049","article-title":"The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"11","author":"Zhao","year":"2022","journal-title":"Cells"},{"key":"R345-20260910","first-page":"818","article-title":"RNA-binding proteins in amyotrophic lateral sclerosis","volume":"41","author":"Zhao","year":"2018","journal-title":"Mol Cells"},{"key":"R346-20260910","doi-asserted-by":"crossref","first-page":"1522073","DOI":"10.3389\/fnagi.2025.1522073","article-title":"Optineurin overexpression ameliorates neurodegeneration through regulating neuroinflammation and mitochondrial quality in a murine model of amyotrophic lateral sclerosis","volume":"17","author":"Zhao","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"R347-20260910","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.abb.2019.01.024","article-title":"Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model","volume":"663","author":"Zhou","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"R348-20260910","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1007\/s12035-016-9888-0","article-title":"Mutation screening of the CHCHD10 gene in Chinese patients with amyotrophic lateral sclerosis","volume":"54","author":"Zhou","year":"2017","journal-title":"Mol Neurobiol"},{"key":"R349-20260910","doi-asserted-by":"crossref","first-page":"368504231184320","DOI":"10.1177\/00368504231184320","article-title":"Potential effects of brain lipid binding protein in the pathogenesis of amyotrophic lateral sclerosis","volume":"106","author":"Zhou","year":"2023","journal-title":"Sci Prog"},{"key":"R350-20260910","doi-asserted-by":"crossref","first-page":"1189470","DOI":"10.3389\/fnins.2023.1189470","article-title":"Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis","volume":"17","author":"Zhou","year":"2023","journal-title":"Front Neurosci"},{"key":"R351-20260910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369466","article-title":"An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis\u2019s disease-like transgenic (G93A SOD1) mice","volume":"15","author":"Zhou","year":"2015","journal-title":"Neurodegener Dis"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-25-00221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:00:50Z","timestamp":1789023650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-25-00221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":351,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-25-00221","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"2025-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}